Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Dirk

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Plos One|November 23, 2013
Tumor mutation burden forecasts outcome in ovarian cancer with BRCA1 or BRCA2 mutationsNicolai Juul Birkbak, Bose Kochupurakkal, Jose M G Izarzugaza, et al.
Science Signaling|July 23, 2009
SIK1 couples LKB1 to p53-dependent anoikis and suppresses metastasisHailing Cheng, Pixu Liu, Zhigang C Wang, et al.
Molecular & Cellular Proteomics : MCP|April 27, 2012
DNA ends alter the molecular composition and localization of Ku multicomponent complexesGuillaume Adelmant, Anne S Calkins, Brijesh K Garg, et al.
Annals of Surgical Oncology|November 7, 2015
Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In-situ in Patients with Lobular Neoplasia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 020)Faina Nakhlis, Lauren Gilmore, Rebecca Gelman, et al.
Molecular Cancer Research : MCR|December 10, 2013
NF-κB activation-induced anti-apoptosis renders HER2-positive cells drug resistant and accelerates tumor growthShannon T Bailey, Penelope L Miron, Yoon J Choi, et al.
Plos One|June 7, 2013
Digital quantification of gene expression in sequential breast cancer biopsies reveals activation of an immune responseRinath M Jeselsohn, Lillian Werner, Meredith M Regan, et al.
Cancer Research|June 17, 2010
PIK3CA mutations in in situ and invasive breast carcinomasAlexander Miron, Maria Varadi, Daniel Carrasco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2007
Predictors of resistance to preoperative trastuzumab and vinorelbine for HER2-positive early breast cancerLyndsay N Harris, Fanglei You, Stuart J Schnitt, et al.
Cell|September 26, 2015
CDK7-dependent transcriptional addiction in triple-negative breast cancerYubao Wang, Tinghu Zhang, Nicholas Kwiatkowski, et al.
Cancer Discovery|May 12, 2012
Telomeric allelic imbalance indicates defective DNA repair and sensitivity to DNA-damaging agentsNicolai J Birkbak, Zhigang C Wang, Ji-Young Kim, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Plos One|November 23, 2013
Tumor mutation burden forecasts outcome in ovarian cancer with BRCA1 or BRCA2 mutationsNicolai Juul Birkbak, Bose Kochupurakkal, Jose M G Izarzugaza, et al.
Science Signaling|July 23, 2009
SIK1 couples LKB1 to p53-dependent anoikis and suppresses metastasisHailing Cheng, Pixu Liu, Zhigang C Wang, et al.
Molecular & Cellular Proteomics : MCP|April 27, 2012
DNA ends alter the molecular composition and localization of Ku multicomponent complexesGuillaume Adelmant, Anne S Calkins, Brijesh K Garg, et al.
Annals of Surgical Oncology|November 7, 2015
Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In-situ in Patients with Lobular Neoplasia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 020)Faina Nakhlis, Lauren Gilmore, Rebecca Gelman, et al.
Molecular Cancer Research : MCR|December 10, 2013
NF-κB activation-induced anti-apoptosis renders HER2-positive cells drug resistant and accelerates tumor growthShannon T Bailey, Penelope L Miron, Yoon J Choi, et al.
Plos One|June 7, 2013
Digital quantification of gene expression in sequential breast cancer biopsies reveals activation of an immune responseRinath M Jeselsohn, Lillian Werner, Meredith M Regan, et al.
Cancer Research|June 17, 2010
PIK3CA mutations in in situ and invasive breast carcinomasAlexander Miron, Maria Varadi, Daniel Carrasco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2007
Predictors of resistance to preoperative trastuzumab and vinorelbine for HER2-positive early breast cancerLyndsay N Harris, Fanglei You, Stuart J Schnitt, et al.
Cell|September 26, 2015
CDK7-dependent transcriptional addiction in triple-negative breast cancerYubao Wang, Tinghu Zhang, Nicholas Kwiatkowski, et al.
Cancer Discovery|May 12, 2012
Telomeric allelic imbalance indicates defective DNA repair and sensitivity to DNA-damaging agentsNicolai J Birkbak, Zhigang C Wang, Ji-Young Kim, et al.
Pageof 6